• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751

Comprehensive Guide to rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate (CAS No. 895245-30-4)

rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate (CAS No. 895245-30-4) is a chiral pyrrolidine derivative with significant applications in pharmaceutical synthesis and organic chemistry. This compound, often referred to as a protected amino alcohol, is widely utilized as a building block in the development of bioactive molecules. Its unique structural features, including the tert-butyl carbamate (Boc) protecting group and dual hydroxymethyl functionalities, make it a versatile intermediate for drug discovery and asymmetric synthesis.

The growing demand for chiral auxiliaries and pharmaceutical intermediates has placed compounds like rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate at the forefront of modern synthetic chemistry. Researchers frequently search for high-purity chiral building blocks and Boc-protected pyrrolidines, making this compound a topic of interest in academic and industrial settings. Its role in the synthesis of protease inhibitors and enzyme modulators further enhances its relevance in drug development pipelines.

One of the key advantages of rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate is its compatibility with various coupling reactions, such as Mitsunobu reactions and peptide bond formations. The presence of the Boc group allows for selective deprotection under mild acidic conditions, enabling further functionalization of the pyrrolidine core. This flexibility is particularly valuable in the design of peptidomimetics and small molecule therapeutics, where precise control over molecular architecture is crucial.

In recent years, the compound has gained attention in the context of green chemistry and sustainable synthesis. Researchers are exploring eco-friendly methods for producing chiral pyrrolidine derivatives, including catalytic asymmetric hydrogenation and biocatalytic approaches. The hydroxymethyl groups in rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate can serve as handles for further modifications, enabling the creation of diverse molecular libraries with potential biological activities.

The analytical characterization of rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate typically involves techniques such as nuclear magnetic resonance (NMR) spectroscopy, high-performance liquid chromatography (HPLC), and mass spectrometry (MS). These methods ensure the compound's purity and stereochemical integrity, which are critical for its applications in medicinal chemistry. The compound's stability under standard storage conditions (typically at room temperature or below) makes it a practical choice for laboratory use.

From a commercial perspective, rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate is available from specialized chemical suppliers who cater to the pharmaceutical research and fine chemicals markets. The pricing and availability of this compound may vary depending on the scale of purchase and the required purity level (typically ranging from 95% to 99%). Current market trends show increasing demand for such chiral synthons, driven by the expanding pipeline of targeted therapies and precision medicines.

Future research directions for rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate may include its application in bioconjugation chemistry and drug delivery systems. The compound's hydroxyl groups could potentially be modified to create prodrug formulations or linked to targeting moieties for enhanced therapeutic specificity. As the field of personalized medicine continues to grow, the importance of well-characterized building blocks like this pyrrolidine derivative is expected to rise accordingly.

For researchers working with rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate, proper handling procedures should always be followed, including the use of appropriate personal protective equipment (PPE) and adherence to standard laboratory safety protocols. While the compound is not classified as hazardous under normal conditions, good laboratory practice dictates careful management of all chemical substances.

In summary, rac-tert-butyl (3R,4R)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate (CAS No. 895245-30-4) represents an important tool in modern synthetic organic chemistry, particularly for pharmaceutical applications. Its combination of chirality, protecting group chemistry, and multiple functional handles makes it a valuable asset in drug discovery programs. As synthetic methodologies continue to advance, this compound is likely to find even broader utility in the creation of novel bioactive molecules.

• 895245-31-5(tert-butyl trans-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate)
• 146257-05-8(tert-Butyl 3-(methoxymethyl)pyrrolidine-1-carboxylate)
• 1184985-22-5(tert-butyl 3-(hydroxymethyl)-4-methyl-pyrrolidine-1-carboxylate)
• 1263506-20-2(Tert-butyl 3-(hydroxymethyl)-3-methylpyrrolidine-1-carboxylate)
• 895245-32-6(1-Pyrrolidinecarboxylic acid, 3,4-bis(hydroxymethyl)-, 1,1-dimethylethylester, (3R,4R)-)
• 138108-72-2(tert-butyl (3R)-3-(hydroxymethyl)pyrrolidine-1-carboxylate)
• 114214-69-6(1-Boc-3-(Hydroxymethyl)pyrrolidine)
• 1194376-30-1(tert-butyl 3,3-bis(hydroxymethyl)pyrrolidine-1-carboxylate)
• 199174-24-8(tert-butyl (3S)-3-(hydroxymethyl)pyrrolidine-1-carboxylate)
• 1349715-96-3(Trans-tert-butyl 3-(hydroxymethyl)-4-methylpyrrolidine-1-carboxylate)